MEPOLIZUMAB

22295 reported adverse events

Drug classes: Interleukin-5 Antagonist [EPC]

These side effects are most commonly reported by patients taking MEPOLIZUMAB:

# Side effect Count
0 ASTHMA 7516
1 DYSPNOEA 5985
2 WHEEZING 4192
3 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3353
4 COUGH 2960
5 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2698
6 PNEUMONIA 2107
7 DRUG INEFFECTIVE 1991
8 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1919
9 BLOOD COUNT ABNORMAL 1791
See all common reactions for MEPOLIZUMAB

MEPOLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CFTR GENE MUTATION 10 0.9091
1 PLETHYSMOGRAPHY 17 0.8947
2 BRONCHIAL NEOPLASM BENIGN 11 0.7857
3 BRONCHOLITHIASIS 18 0.7826
4 INSPIRATORY CAPACITY ABNORMAL 16 0.6400
5 HEART SOUNDS 36 0.5902
6 SPUTUM CULTURE 15 0.5769
7 AIRWAY REMODELLING 35 0.4795
8 FORCED EXPIRATORY VOLUME 14 0.4516
9 TOTAL LUNG CAPACITY INCREASED 53 0.4417
See all enriched reactions for MEPOLIZUMAB